Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Fortress and its majority-owned subsidiary, Cyprium Therapeutics, said the FDA has accepted an NDA resubmission for CUTX-101, or copper histidinate, a treatment for children who suffer from Menkes ...

BioLizard has supported the development of novel biomarker programs, contributed to AI-driven drug discovery efforts, and ...

A professor with a research portfolio in ag biotechnology says there is little interest in mandatory GMO labelling among ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

This company has lodged a key submission which will pave the way for sales of its heart failure software in the large US ...

Billionaire investor Jim Mellon has revealed plans to bring large-scale “clean food” manufacturing to the Middle East, positioning the UAE as a future global hub for precision-fermented proteins and ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

Opportunities lie in automated platforms, adaptable solutions for diverse processes, and strategic alliances to enhance ...

Siddhartha Mukherjee, oncologist and author of “The Emperor of All Maladies,” asks: What if we change what a tumor can eat?

Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct tri-specific antibodies, IM1240 and IM1305, targeting different tumor antigens ...

Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of ...